ALFA Filings
Every announcement, straight from the exchange
Every Alembic Pharmaceuticals debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
10 announcements with these filters
Alembic Pharmaceuticals submitted a certificate confirming the utilization of proceeds from Commercial Papers for the quarter ended September 30, 2026, as required by SEBI regulations.
Alembic Pharmaceuticals has redeemed commercial papers worth ₹200 Crore on their maturity date, 28th September 2026. This confirms the company's full repayment of the debt obligation.
Alembic Pharmaceuticals Limited has redeemed Commercial Papers (CP) worth Rs. 100 Crores. The redemption was completed on the maturity date of September 25, 2026.
Alembic Pharmaceuticals has redeemed Commercial Papers worth Rs. 150 Crore upon maturity on 23rd September 2026.
Alembic Pharmaceuticals has successfully redeemed Commercial Papers worth ₹150 Crore upon maturity. This confirms the repayment of the company's debt obligation.
Alembic Pharmaceuticals redeemed its Commercial Papers of Rs. 150 Crores on the maturity date. This confirms timely debt repayment, reducing outstanding liabilities.
Alembic Pharmaceuticals Limited redeemed Commercial Papers worth ₹100 Crore on their maturity date. This redemption reduces the company's short-term debt obligations and interest burden.
Alembic Pharmaceuticals announced record dates for the maturity of Commercial Papers totaling ₹250 Crore. This disclosure confirms upcoming debt repayments and maintains financial transparency.
Alembic Pharmaceuticals successfully redeemed Commercial Papers worth ₹150 Crore on their maturity date of May 29, 2026. This reflects disciplined debt management and liquidity.
Alembic Pharmaceuticals Limited redeemed Commercial Papers worth ₹150 Crore on their maturity date. This successful repayment demonstrates the company's strong liquidity and financial discipline.